United States

AMAG Pharmaceuticals Inc (AMAG.OQ)

AMAG.OQ on NASDAQ Stock Exchange Global Select Market

23 Mar 2017
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Select another date:

Tue, Feb 14 2017

BRIEF-Amag Pharmaceuticals, Endoceutics enter into license agreement

* Amag and Endoceutics enter into an exclusive U.S. license agreement for intrarosa (prasterone)

BRIEF-Amag Pharmaceuticals sees Q4 2016 revenue $150 mln to $155 mln

* AMAG Pharmaceuticals provides financial and business update

BRIEF-Amag Pharmaceuticals enters into an agreement to develop and commercialize Rekynda

* Entered into an agreement for exclusive North American rights to develop and commercialize Rekynda

BRIEF-Amag Pharma Q3 earnings per share $0.43

* Amag pharmaceuticals reports third quarter 2016 financial results and provides corporate update

Select another date:

More From Around the Web